Autism Spectrum DisorderNCT05520632
Autism Spectrum Disorder: BAEPs Findings and Behavioral Responses to Sounds
An observational study of Autism Spectrum Disorder, run by Instituto de Ciências Biomédicas Abel Salazar at 1 site in Portugal.
Trial summary
There are many studies in the literature that study the sensory profile of children with autism spectrum disorder (ASD), which can essentially have three types of behavior: (1) Registration, (2) Seeking, (3) Sensitivity, and (4) Avoiding. Read more about this study
- Who is it for?
- Ages 3 to 6 yearsHealthy volunteers can take part
- Conditions the study is for
- Autism Spectrum Disorder
- What is being tested?
- Brainstem Auditory Evoked Potentials
- How many people
- 120 participants
- Where
- 1 sitePortugal
- Study dates
- 1 May 2022to 1 Dec 2026
- How long will I take part?
- 3 Years
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 3 to 6 years
- All sexes
- Healthy volunteers accepted
- Child
Study population: All cases as children sent/followed up in the Development Consultation - Pediatrics, Pedopsychiatry or Pediatric Neurology diagnosed with ASD aged between 2 and 6 years (possible cases) and all children aged between 2 and 6 years who had scheduled PEATC in the ENT service in routine care (possible controls)
Who may be able to join
- Case group: children diagnosed with ASD according to the DSM-V criteria (Diagnostic and Statistical Manual of Mental Disorders 5th edition) and performed by a Pediatrician, Pedopsychiatry or Pediatric Neurologist; age between 3 and 6 years at the time of the audiological assessment; children with indication for BAEP; children who reveal thresholds within the normal range in the BAEP.
- Control group: children with typical development for their age; children with indication for BAEP due to the presence of risk factors for deafness (included in the universal neonatal auditory screening program) or due to delay in language development alone requiring clarification; age between 3 and 6 years at the time of audiological examinations; children who reveal thresholds within the normal range in the BAEP.
Who cannot join
- Case group: late diagnosis of ASD (> 6 years); associated pathology, such as: neurological (epilepsy, neurodegenerative disease, severe hypoxic-ischemic encephalopathy), congenital infections (TORCH group infections) with hearing impairment, chromosomal abnormalities (Down syndrome, fragile X syndrome), neurocutaneous syndromes, endocrine disorders and metabolic disorders (phenylketonuria), cleft palate or facial malformations; active ear pathology at the time of audiological evaluation (otitis media, external auditory canal infection or malformation); increase in auditory thresholds in BAEP.
- Control group: associated pathology, such as: neurological (epilepsy, neurodegenerative disease, severe hypoxic-ischemic encephalopathy), congenital infections (TORCH group infections) with hearing loss, chromosomal abnormalities (Down syndrome, fragile X syndrome), neurocutaneous syndromes , endocrine and metabolic disorders (phenylketonuria), cleft palate or facial malformations; active ear pathology at the time of audiological evaluation (otitis media, external auditory canal infection or malformation); increase in auditory thresholds in BAEP.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Portugal1 site, 1 recruiting
- Recruiting
Instituto de Ciências Biomédicas Abel Salazar da Universidade do Porto (Abel Salazar Biomedical Sciences Institute - University of Porto)
Porto, 4050-313
Joana Raquel Correia Carvalho da Costa, 918109458, joana_cccosta@hotmail.com
About this study
Official title: Autism Spectrum Disorder: Brainstem Auditory Evoked Potential Findings and Behavioral Responses to Sounds
There are many studies in the literature that study the sensory profile of children with autism spectrum disorder (ASD), which can essentially have three types of behavior: (1) Registration, (2) Seeking, (3) Sensitivity, and (4) Avoiding. However, there are few studies dedicated to the study of the sensory profile of children with autism. A child's sensory profile is closely related to the way they deal with the world and their social interaction. The existence of tools that allow the study of the behavioral response to the sounds of children with autism spectrum disorder, will allow the application of targeted therapies in the future. Therapies targeted and adjusted to each profile observed in these children will allow to attenuate these maladjusted behavioral responses, or even overcome these deficits, if there is an early and precise intervention.
Read the detailed description
The objectives of this work are:
PRIMARY OBJECTIVES:
- To characterize the BAEP findings in children with ASD (case group) and compare these findings with those obtained in children matched by sex and age without suspected ASD (control group), with a special focus on the study of the following parameters:
- Wave I amplitude and wave V/wave I amplitude ratio (V/I ratio)
- Extension of the absolute latency of wave V With the aim of:
- Establish and describe a possible pattern in the BAEP that characterizes children with ASD
- To characterize the subgroup of children with ASD who present alterations in the BAEP: understand if changes in BAEPs appear in children with more severe autism, if it depends on gender, if it depends on the auditory profile.
- Characterize the Behavioral Response to Sounds of children with ASD
- Application and validation for Portuguese of the Auditory Behavior Questionnaire (ABQ)
- Application of Child Sensory Profile 2 (CSP2) With the aim of. > To characterize the audiological profile of children with ASD
- To establish, among children with ASD, a relationship between the specific findings in the BAEP and different behavioral responses to sound.
SECONDARY OBJECTIVES:
- Collect and analyze demographic data;
- Collect and analyze the personal (pre, peri and postnatal) and family history of each participant;
- Assess the degree of global development and in particular the hearing/language parameter through data collected from the Griffiths Mental Development Scale;
- Characterize ASD in terms of severity, clinician/specialty that made the diagnosis;
- Evaluate other additional parameters of the BAEP: describe the uni or bilaterality of the findings; analyze the latency of waves III and increase in interpeak intervals for waves I-III and I-V.
MATERIAL AND METHODS
- Study design: Analytical observational case-control study
- Participants This study will include children between 3 and 6 years of age, observed consecutively at the Otorhinolaryngology Service of the Porto University Hospital Center and the Pediatrics Service of the Northern Mother and Child Center (belonging to the Porto University Hospital Center), with a diagnosis of ASD. with indication for performing BAEP.
- Study groups The sample will be divided into two groups:
- Children with ASD (ASD Group): cases
- Children without diagnosis or suspicion of ASD (Group without ASD): control
- Recruitment All children sent/followed at the Development Consultation - Pediatrics, Pedopsychiatry or Pediatric Neurology diagnosed with ASD aged between 2 and 6 years (potential cases) and all children aged between 2 and 6 years who have BAEP appointments in the Otorhinolaryngology department (potential controls) will be sent to the principal investigator. Thus, a consecutive and progressive recruitment of participants will be carried out. Parents or guardians of children who meet the inclusion criteria will be asked about their availability and interest in participating in the study, explaining the purpose of the study. An Information Leaflet for Participants has been created. If they wanted to participate in the study after being duly informed, an Informed Consent Term is delivered and signed. An individual data collection sheet was also created for data collection by the researcher. Data obtained from the electronic clinical file and provided by the parents. The aforementioned and scheduled BAEP questionnaires will be applied. After performing the BAEP, a new consultation is scheduled with the parents/legal guardians, where the result of the new assessment in terms of sensory and auditory profile, as well as the results of the BAEP will be made known. All data collected will go into a database created for this purpose.
- Time line
This study will be developed in 4 main stages:
- st PHASE: Preparation phase
- Elaboration of the Study Protocol
- Submission of the Project to the Ethics Committee
- Preparation of information leaflets, consents, sheet/database for data collection
- Creation of referral routes between the Principal Investigator and the doctors dedicated to the Development Consultation - Pediatrics, who deal with children diagnosed with ASD and with the audiologists responsible for carrying out the BAEP, in order to constitute the study sample.
- Translation and validation of the Auditory Behavior Questionnaire
- nd PHASE: Selection of possible study patients and data collection
- Consecutive and progressive recruitment of participants. At this stage, the parents of children who meet the inclusion and exclusion criteria will be summoned, and asked about their availability to participate in the study;
- The respondents that make up the study will be applied;
- Will be requested by the BAEP researcher
- rd PHASE: Creation of a database
- Collection of information from BAEP;
- All information collected and recorded on the "Individual Data Collection Sheet" in phase 2 of the study will be transferred to a database.
- th PHASE: Data analysis and interpretation of results (2 months) The researchers and statistical analysts, using the appropriate statistical tests, will proceed to the analysis of the collected data. Subsequently, an interpretation will be made of the results of the study and a comparison with existing data in the literature in order to draw up the conclusions of the study and its dissemination in Research Article format and its presentation in free communication format at scientific events. .
- Ethical considerations
During the realization of this study, we will act according to the medical ethics requirements defined in the World Medical Association Declaration of Helsinki - Ethical Principles for Medical Research Involving Human Subjects. Thus, this project was submitted to the Ethics Committee for Health of the Porto University Hospital Center, obtaining a favorable opinion in May/2022 (2021-124 (101-DEFI/104-CE)).
- Conditions
- Autism Spectrum Disorder
- Being tested
- Brainstem Auditory Evoked Potentials
- Medical subject headings
- Autism Spectrum Disorder
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Brainstem Auditory Evoked PotentialsDiagnostic test
Performing Brainstem Auditory Evoked Potentials under sedation
| Study group | Role | What they receive |
|---|---|---|
| Children without autism spectrum disorder | Children without autism spectrum disorder undergoing BAEP Receives: Diagnostic Test: Brainstem Auditory Evoked Potentials | |
| Children with autism spectrum disorder | Children with autism spectrum disorder undergoing BAEP Receives: Diagnostic Test: Brainstem Auditory Evoked Potentials |
What is being measured
The primary outcome is the main question the study is designed to answer.
Findings in Brainstem Auditory Evoked Potentials (BAEP)
Brainstem Auditory Evoked Potentials will be performed under propofol sedation. Absolute latencies (ALs) of waves I, III, and V and interpeak latencies (IPLs) I-III, III-V, and I-V were measured, as well as the amplitudes of waves I and V. These values will be compared between the group of cases (children with ASD) and controls (children without ASD). It will be evaluated whether any of these values will be persistently outside the values considered normal in children with ASD.
Measured: 3 years
Secondary outcomes (2)
Study of the sensory profile of children with autism spectrum disorder applying the "Child Sensory Profile 2" questionnaire
Application of the questionnaire "Child Sensory Profile 2" (CSP2) and determine which category stands out: (1) Registration, (2) Seeking, (3) Sensitivity, and (4) Avoiding.
A 5-point Likert scale (1 = almost never, 2 = occasionally, 3 = Half the time, 4 = Frequently, 5 = Almost always) will be applied to each question. A standard factor score close to zero suggests a child exhibits behaviors in that factor domain that are consistent with the majority of children. A more positive standard factor score suggests the child displays more of the observed behaviors associated with that domain than other children in this sample with ASD.
A raw score total will be obtained for each category. Scores one standard deviation or more from the mean as expressed as "More than Others" or "Less than Others". Scotes two standard deviations or more from the mean area expressed as "Much more than the Others" or "Much less than Others", respectively.
Measured: 3 years
Study of the auditory profile of children with autism spectrum disorder applying the"Auditory Behavior Questionnaire" questionnaire
Application of the questionnaire "Auditory Behavior Questionnaire" (ABR) and determine which category stands out in terms of auditory profile: (1) Registration, (2) Seeking, (3) Sensitivity, and (4) Avoiding.
A 5-point Likert scale (1 = Never, 2 = Rarely, 3 = Sometimes, 4 = Often, 5 = Very Often.
A a score close to zero suggests a child exhibits behaviors in that factor domain that is consistent with the majority of children with ASD. If a child has a negative standard score then the behaviors are less prevalent associated with that factor domain. A more positive standard score suggests more difficulty in the specified factor and a higher prevalence of the observed behaviors for that child.
Measured: 3 years
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted30 Aug 2022
- Study start1 May 2022
- Primary completion1 May 2023 (estimated)
- Study completion1 Dec 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Autism Spectrum DisorderStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case-control
- Time perspective
- Prospective
- Enrolment
- 120 participants (estimated)
- Target duration
- 3 Years
Sponsor and investigators
- Lead sponsor
- Instituto de Ciências Biomédicas Abel Salazar
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Joana Costa, Principal investigator, Instituto de Ciências Biomédicas Abel Salazar
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05520632
- Sponsor's protocol ID
- 2021.124(101.DEFI/104-CE)
- Status last verified
- Aug 2022
- First submitted
- 22 Aug 2022
- Last updated
- 30 Aug 2022
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 30 Aug 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Autism Spectrum Disorder: Brainstem Auditory Evoked Potential Findings and Behavioral Responses to Sounds
- ClinicalTrials.gov ID
- NCT05520632
- Acronym / sponsor ID
- 2021.124(101.DEFI/104-CE)
- Conditions
- Autism Spectrum Disorder
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 120 participants (estimated)
- Lead sponsor
- Instituto de Ciências Biomédicas Abel SalazarUniversity, hospital or other
- Study start
- 1 May 2022 (actual)
- Primary completion
- 1 May 2023 (estimated)
- Study completion
- 1 Dec 2026 (estimated)
- First posted
- 30 Aug 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
There are many studies in the literature that study the sensory profile of children with autism spectrum disorder (ASD), which can essentially have three types of behavior: (1) Registration, (2) Seeking, (3) Sensitivity, and (4) Avoiding. However, there are few studies dedicated to the study of the sensory profile of children with autism. A child's sensory profile is closely related to the way they deal with the world and their social interaction. The existence of tools that allow the study of the behavioral response to the sounds of children with autism spectrum disorder, will allow the application of targeted therapies in the future. Therapies targeted and adjusted to each profile observed in these children will allow to attenuate these maladjusted behavioral responses, or even overcome these deficits, if there is an early and precise intervention.
Detailed description
The objectives of this work are:
PRIMARY OBJECTIVES:
- To characterize the BAEP findings in children with ASD (case group) and compare these findings with those obtained in children matched by sex and age without suspected ASD (control group), with a special focus on the study of the following parameters:
- Wave I amplitude and wave V/wave I amplitude ratio (V/I ratio)
- Extension of the absolute latency of wave V With the aim of:
- Establish and describe a possible pattern in the BAEP that characterizes children with ASD
- To characterize the subgroup of children with ASD who present alterations in the BAEP: understand if changes in BAEPs appear in children with more severe autism, if it depends on gender, if it depends on the auditory profile.
- Characterize the Behavioral Response to Sounds of children with ASD
- Application and validation for Portuguese of the Auditory Behavior Questionnaire (ABQ)
- Application of Child Sensory Profile 2 (CSP2) With the aim of. > To characterize the audiological profile of children with ASD
- To establish, among children with ASD, a relationship between the specific findings in the BAEP and different behavioral responses to sound.
SECONDARY OBJECTIVES:
- Collect and analyze demographic data;
- Collect and analyze the personal (pre, peri and postnatal) and family history of each participant;
- Assess the degree of global development and in particular the hearing/language parameter through data collected from the Griffiths Mental Development Scale;
- Characterize ASD in terms of severity, clinician/specialty that made the diagnosis;
- Evaluate other additional parameters of the BAEP: describe the uni or bilaterality of the findings; analyze the latency of waves III and increase in interpeak intervals for waves I-III and I-V.
MATERIAL AND METHODS
- Study design: Analytical observational case-control study
- Participants This study will include children between 3 and 6 years of age, observed consecutively at the Otorhinolaryngology Service of the Porto University Hospital Center and the Pediatrics Service of the Northern Mother and Child Center (belonging to the Porto University Hospital Center), with a diagnosis of ASD. with indication for performing BAEP.
- Study groups The sample will be divided into two groups:
- Children with ASD (ASD Group): cases
- Children without diagnosis or suspicion of ASD (Group without ASD): control
- Recruitment All children sent/followed at the Development Consultation - Pediatrics, Pedopsychiatry or Pediatric Neurology diagnosed with ASD aged between 2 and 6 years (potential cases) and all children aged between 2 and 6 years who have BAEP appointments in the Otorhinolaryngology department (potential controls) will be sent to the principal investigator. Thus, a consecutive and progressive recruitment of participants will be carried out. Parents or guardians of children who meet the inclusion criteria will be asked about their availability and interest in participating in the study, explaining the purpose of the study. An Information Leaflet for Participants has been created. If they wanted to participate in the study after being duly informed, an Informed Consent Term is delivered and signed. An individual data collection sheet was also created for data collection by the researcher. Data obtained from the electronic clinical file and provided by the parents. The aforementioned and scheduled BAEP questionnaires will be applied. After performing the BAEP, a new consultation is scheduled with the parents/legal guardians, where the result of the new assessment in terms of sensory and auditory profile, as well as the results of the BAEP will be made known. All data collected will go into a database created for this purpose.
- Time line
This study will be developed in 4 main stages:
- st PHASE: Preparation phase
- Elaboration of the Study Protocol
- Submission of the Project to the Ethics Committee
- Preparation of information leaflets, consents, sheet/database for data collection
- Creation of referral routes between the Principal Investigator and the doctors dedicated to the Development Consultation - Pediatrics, who deal with children diagnosed with ASD and with the audiologists responsible for carrying out the BAEP, in order to constitute the study sample.
- Translation and validation of the Auditory Behavior Questionnaire
- nd PHASE: Selection of possible study patients and data collection
- Consecutive and progressive recruitment of participants. At this stage, the parents of children who meet the inclusion and exclusion criteria will be summoned, and asked about their availability to participate in the study;
- The respondents that make up the study will be applied;
- Will be requested by the BAEP researcher
- rd PHASE: Creation of a database
- Collection of information from BAEP;
- All information collected and recorded on the "Individual Data Collection Sheet" in phase 2 of the study will be transferred to a database.
- th PHASE: Data analysis and interpretation of results (2 months) The researchers and statistical analysts, using the appropriate statistical tests, will proceed to the analysis of the collected data. Subsequently, an interpretation will be made of the results of the study and a comparison with existing data in the literature in order to draw up the conclusions of the study and its dissemination in Research Article format and its presentation in free communication format at scientific events. .
- Ethical considerations
During the realization of this study, we will act according to the medical ethics requirements defined in the World Medical Association Declaration of Helsinki - Ethical Principles for Medical Research Involving Human Subjects. Thus, this project was submitted to the Ethics Committee for Health of the Porto University Hospital Center, obtaining a favorable opinion in May/2022 (2021-124 (101-DEFI/104-CE)).
Study design
- Observational model
- Case-control
- Time perspective
- Prospective
- Target follow-up
- 3 Years
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Children without autism spectrum disorder | – | Diagnostic Test: Brainstem Auditory Evoked PotentialsChildren without autism spectrum disorder undergoing BAEP |
| Children with autism spectrum disorder | – | Diagnostic Test: Brainstem Auditory Evoked PotentialsChildren with autism spectrum disorder undergoing BAEP |
Who may qualify
- Ages
- 3 to 6 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child
- Study population
- All cases as children sent/followed up in the Development Consultation - Pediatrics, Pedopsychiatry or Pediatric Neurology diagnosed with ASD aged between 2 and 6 years (possible cases) and all children aged between 2 and 6 years who had scheduled PEATC in the ENT service in routine care (possible controls)
Key inclusion criteria (2 listed)
- Case group: children diagnosed with ASD according to the DSM-V criteria (Diagnostic and Statistical Manual of Mental Disorders 5th edition) and performed by a Pediatrician, Pedopsychiatry or Pediatric Neurologist; age between 3 and 6 years at the time of the audiological assessment; children with indication for BAEP; children who reveal thresholds within the normal range in the BAEP.
- Control group: children with typical development for their age; children with indication for BAEP due to the presence of risk factors for deafness (included in the universal neonatal auditory screening program) or due to delay in language development alone requiring clarification; age between 3 and 6 years at the time of audiological examinations; children who reveal thresholds within the normal range in the BAEP.
Key exclusion criteria (2 listed)
- Case group: late diagnosis of ASD (> 6 years); associated pathology, such as: neurological (epilepsy, neurodegenerative disease, severe hypoxic-ischemic encephalopathy), congenital infections (TORCH group infections) with hearing impairment, chromosomal abnormalities (Down syndrome, fragile X syndrome), neurocutaneous syndromes, endocrine disorders and metabolic disorders (phenylketonuria), cleft palate or facial malformations; active ear pathology at the time of audiological evaluation (otitis media, external auditory canal infection or malformation); increase in auditory thresholds in BAEP.
- Control group: associated pathology, such as: neurological (epilepsy, neurodegenerative disease, severe hypoxic-ischemic encephalopathy), congenital infections (TORCH group infections) with hearing loss, chromosomal abnormalities (Down syndrome, fragile X syndrome), neurocutaneous syndromes , endocrine and metabolic disorders (phenylketonuria), cleft palate or facial malformations; active ear pathology at the time of audiological evaluation (otitis media, external auditory canal infection or malformation); increase in auditory thresholds in BAEP.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Brainstem Auditory Evoked PotentialsPerforming Brainstem Auditory Evoked Potentials under sedation | Diagnostic test | Children with autism spectrum disorder, Children without autism spectrum disorder |
Primary outcome
Findings in Brainstem Auditory Evoked Potentials (BAEP)
Time frame: 3 years
Brainstem Auditory Evoked Potentials will be performed under propofol sedation. Absolute latencies (ALs) of waves I, III, and V and interpeak latencies (IPLs) I-III, III-V, and I-V were measured, as well as the amplitudes of waves I and V. These values will be compared between the group of cases (children with ASD) and controls (children without ASD). It will be evaluated whether any of these values will be persistently outside the values considered normal in children with ASD.
2 secondary outcomes
Study of the sensory profile of children with autism spectrum disorder applying the "Child Sensory Profile 2" questionnaire
Time frame: 3 years
Study of the auditory profile of children with autism spectrum disorder applying the"Auditory Behavior Questionnaire" questionnaire
Time frame: 3 years
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 30 Aug 2022.
Related trials for Autism Spectrum Disorder
RecruitingPhase 1
Cannabidiol (CBD) in Adults With ASD
Autism Spectrum Disorder
RecruitingPhase 3
A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
Schizophrenia, Autism-Related Irritability
Not yet recruiting
Sensory-integration Therapy Verses Augumented Reality-based Training in ASD
Autism Spectrum Disorder
Recruiting
Cumulative and Booster Effects of Multisession Prefrontal tDCS in ASD Adolescents
Transcranial Direct Current Stimulation, Autistic Spectrum Disorder
Not yet recruiting
"Family Resilience And Mind-body Enhancement" (FRAME): A Randomised Controlled Trial
Autism
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Joana Costa principal investigator
Instituto de Ciências Biomédicas Abel Salazar
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Autism Spectrum Disorder, run by Instituto de Ciências Biomédicas Abel Salazar at 1 site in Portugal.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 30 Aug 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Portugal. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Joana Costa, MD (00351918109458, joana_cccosta@hotmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Findings in Brainstem Auditory Evoked Potentials (BAEP) (time frame: 3 years). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Aug 2022.